Grants & Giving
Kiniksa is committed to improving healthcare and discovering treatments for the patients who need it most. We provide grants, sponsorships, and programs to help advance the understanding of diseases aligned with our therapeutic areas of interest within the medical and patient communities. We also support educational initiatives led by organizations focused on patient advocacy, community education, and other scientific endeavors.
Medical Education Grants
Kiniksa may provide education grants to support independent accredited or non‐accredited activities that aim to educate or inform healthcare professionals (HCPs) or the public about diseases or disease management in therapeutic areas of interest to Kiniksa. Kiniksa will neither influence the content nor have control over independent medical education grants. Kiniksa will consider grants supporting live and virtual education opportunities (conferences/meetings, seminars, webinars, asynchronous enduring content) from academic medical centers, medical education companies, and medical specialty societies.
Medical Educational Areas of Interest include, but are not limited to, the following:
- Increase awareness of the clinical, humanistic, and economic burden associated with recurrent pericarditis and/or other autoinflammatory diseases (e.g., DIRA, CAPS, cardiac sarcoidosis).
- Describe the role of IL-1α and IL-1β in the pathophysiology of recurrent pericarditis and other autoinflammatory diseases, including implications for disease course and management strategies.
- Highlight current US-based treatment recommendations to support evidence-based decision-making in the management of recurrent pericarditis and other autoinflammatory diseases.
- Review clinical evidence supporting the efficacy and safety of targeted, steroid-sparing therapies for recurrent pericarditis and/or other autoinflammatory diseases.
Audience includes, but are not limited to, the following:
Kiniksa supports independent education tailored to a broad range of HCPs who are involved in diagnosing and treating recurrent pericarditis and autoinflammatory diseases. Audiences of interest may include:
- Cardiologists
- Rheumatologists
- Advanced practitioners (e.g., NPs, PAs)
- Emergency medicine physicians
- Pharmacists
Timing/Review Process
Applications are accepted on a rolling basis throughout the year and are generally reviewed monthly by an internal review committee. Our team will review your request and respond to your submission. Kiniksa provides no guarantees that it will provide support for submitted program proposals. Grant requests with multiple external funding sources are preferred.
If you have any questions, please send an email to the administrator at grantsandsponsorships@kiniksa.com.
Medical and Corporate Sponsorships
Kiniksa sponsors programs and events that support, raise awareness, and advance education and scientific knowledge in therapeutic areas of interest to Kiniksa.
Timing/Review Process
Requests are accepted on a rolling basis throughout the year. Our team will review your request and contact you about your submission. Kiniksa provides no guarantees that it will provide support for submitted program proposals.
Sponsorship applications must include associated benefits for each funding level.
If you have any questions, please send an email to the administrator at grantsandsponsorships@kiniksa.com.
3/26 - KIN-US-00001 (v1.0)
Collaborative Research Agreements and Collaborative Study Agreements
Kiniksa recognizes that external collaborations contribute to the advancement of scientific knowledge and can positively impact patient care and clinical outcomes. External collaborations complement our internal research and development programs and may be of mutual interest and benefit to Kiniksa, its collaborators, the scientific and healthcare communities, and patients.
The goal of Kiniksa’s Collaborative Study Program is to support projects that contribute to the advancement of scientific knowledge and patient care.
HOW DOES KINIKSA WORK WITH COLLABORATIVE STUDY PARTNERS?
Kiniksa will collaborate with external partners on shared study objectives that advance scientific knowledge and patient care. Collaborative study proposals can be initiated by an external partner, by Kiniksa, or by both parties. If a proposal is approved, Kiniksa will enter into a Collaborative Study Agreement (CSA) with one or more external partners. The level of involvement for Kiniksa will vary depending on the research proposal.
Kiniksa may provide financial and/or non-financial support to design and conduct non-clinical or clinical research, and interventional or noninterventional studies. Support, if any, will be granted based on scientific merit with consideration to the scientific expertise of the investigator(s) and on congruence with Kiniksa's Areas of Interest, some of which are identified below. The CSA budget must be reasonable and appropriate.
IL-1 PATHWAY AREAS OF INTEREST
Kiniksa may be interested in working collaboratively with leading investigators to explore strategies to further our understanding in the following areas:
- Diagnosis and management of pericardial disease, including duration of disease
- Genetic polymorphisms/markers, biomarkers, and/or imaging to better understand disease pathophysiology/disease duration and guide therapy
- Real-world evidence and natural history
- Long-term outcomes
- Real world evidence to better understand how IL-1 pathway inhibition impacts the management of patients with recurrent pericarditis and where knowledge gaps may still exist
- Triggers, characteristics, and cumulative impact of recurrent pericarditis episodes
- Mechanistic studies to better understand the role of cytokines (including IL-1 isoforms) in cardiovascular disease
- Patient endotype analysis that can identify patients with strong IL-1-driven diseases
HOW DO I SUBMIT A REQUEST?
To contact us regarding collaborative research and collaborative studies, please email our Medical Affairs team at CSA@kiniksa.com.